CN1102527A - 末梢血管舒张剂 - Google Patents

末梢血管舒张剂 Download PDF

Info

Publication number
CN1102527A
CN1102527A CN94190064A CN94190064A CN1102527A CN 1102527 A CN1102527 A CN 1102527A CN 94190064 A CN94190064 A CN 94190064A CN 94190064 A CN94190064 A CN 94190064A CN 1102527 A CN1102527 A CN 1102527A
Authority
CN
China
Prior art keywords
lower alkyl
quinolone
hydrogen atom
phenyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94190064A
Other languages
English (en)
Chinese (zh)
Inventor
藤冈孝文
寺本修二
田中理纪
清水洋
田房不二男
富永道明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of CN1102527A publication Critical patent/CN1102527A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN94190064A 1993-02-16 1994-02-03 末梢血管舒张剂 Pending CN1102527A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26594/93 1993-02-16
JP5026594A JPH06239858A (ja) 1993-02-16 1993-02-16 末梢血管拡張剤

Publications (1)

Publication Number Publication Date
CN1102527A true CN1102527A (zh) 1995-05-10

Family

ID=12197866

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94190064A Pending CN1102527A (zh) 1993-02-16 1994-02-03 末梢血管舒张剂

Country Status (10)

Country Link
US (1) US5591751A (2)
EP (1) EP0636128A1 (2)
JP (1) JPH06239858A (2)
KR (1) KR950700900A (2)
CN (1) CN1102527A (2)
AU (1) AU666259B2 (2)
CA (1) CA2133207A1 (2)
PH (1) PH30979A (2)
TW (1) TW259789B (2)
WO (1) WO1994019339A1 (2)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116143751A (zh) * 2022-07-15 2023-05-23 中国人民解放军军事科学院防化研究院 一种含苯乙烯吡啶的喹喔啉酮化合物及其制备方法

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06239858A (ja) * 1993-02-16 1994-08-30 Otsuka Pharmaceut Co Ltd 末梢血管拡張剤
IL155163A0 (en) * 2000-10-02 2003-10-31 Janssen Pharmaceutica Nv Metabotropic glutamate receptor antagonists
US7612078B2 (en) * 2003-03-31 2009-11-03 Epix Delaware, Inc. Piperidinylamino-thieno[2,3-D] pyrimidine compounds
US20050222175A1 (en) * 2004-03-31 2005-10-06 Dhanoa Dale S New piperidinylamino-thieno[2,3-D] pyrimidine compounds
EP1709012B1 (en) * 2003-12-05 2015-07-29 Janssen Pharmaceutica NV 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose)polymerase inhibitors
US7488736B2 (en) * 2004-05-17 2009-02-10 Epix Delaware, Inc. Thienopyridinone compounds and methods of treatment
US7576211B2 (en) 2004-09-30 2009-08-18 Epix Delaware, Inc. Synthesis of thienopyridinone compounds and related intermediates
US7407966B2 (en) * 2004-10-07 2008-08-05 Epix Delaware, Inc. Thienopyridinone compounds and methods of treatment
US7598265B2 (en) * 2004-09-30 2009-10-06 Epix Delaware, Inc. Compositions and methods for treating CNS disorders
US7487406B2 (en) * 2005-11-29 2009-02-03 International Business Machines Corporation Systems, methods, and media for managing software defects
TW200803855A (en) * 2006-02-24 2008-01-16 Kalypsys Inc Quinolones useful as inducible nitric oxide synthase inhibitors
EP2445877B1 (en) * 2008-12-03 2014-07-23 Nanotherapeutics, Inc. Bicyclic compounds and methods of making and using same
US11377452B2 (en) 2017-01-16 2022-07-05 Drexel University Glutamate transporter activators and methods using same

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5165770A (ja) * 1974-12-04 1976-06-07 Otsuka Pharma Co Ltd Karubosuchirirujudotaino seizoho
JPS5168574A (ja) * 1974-12-07 1976-06-14 Otsuka Pharma Co Ltd Karubosuchirirujudotaino seizoho
JPS51118771A (en) * 1975-04-09 1976-10-18 Otsuka Pharmaceut Co Ltd Method for preparing carbostyryl derivatives
JPS597707B2 (ja) * 1975-06-23 1984-02-20 オオツカセイヤク カブシキガイシヤ カルボスチリルユウドウタイノ セイゾウホウ
JPS52283A (en) * 1975-06-23 1977-01-05 Otsuka Pharmaceut Co Ltd Process for preparation of carbostyril derivatives
JPS5283380A (en) * 1975-12-26 1977-07-12 Otsuka Pharmaceut Co Ltd Synthesis of thiocarbostyril derivatives
JPS52118474A (en) * 1976-03-31 1977-10-04 Otsuka Pharmaceut Co Ltd Alpha-substituted aminoalkanyol-3,4-dihydrocarbostyril derivatives and method of preparing the same
JPS5416478A (en) * 1977-07-08 1979-02-07 Otsuka Pharmaceut Co Ltd 3,4-dihydrocarbostyril herivative
JPS57171974A (en) * 1981-04-15 1982-10-22 Otsuka Pharmaceut Co Ltd Carbostyril derivative
FI77852C (fi) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat.
JPS57154129A (en) * 1981-03-16 1982-09-22 Otsuka Pharmaceut Co Ltd Cardiotonic drug
JPS5929668A (ja) * 1982-08-13 1984-02-16 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
US4845100A (en) * 1985-04-12 1989-07-04 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof, processes for preparing the same and cardiotonic composition containing the same
JPH0696555B2 (ja) * 1986-07-31 1994-11-30 大塚製薬株式会社 カルボスチリル誘導体
US4886809A (en) * 1986-07-31 1989-12-12 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof
US5405602A (en) * 1989-01-31 1995-04-11 Simmons; Paul L. Nonaqueous cold sterilant
EP0382185B1 (en) * 1989-02-10 1994-06-15 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JPH06239858A (ja) * 1993-02-16 1994-08-30 Otsuka Pharmaceut Co Ltd 末梢血管拡張剤

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116143751A (zh) * 2022-07-15 2023-05-23 中国人民解放军军事科学院防化研究院 一种含苯乙烯吡啶的喹喔啉酮化合物及其制备方法
CN116143751B (zh) * 2022-07-15 2025-07-15 中国人民解放军军事科学院防化研究院 一种含苯乙烯吡啶的喹喔啉酮化合物及其制备方法

Also Published As

Publication number Publication date
US5591751A (en) 1997-01-07
KR950700900A (ko) 1995-02-20
JPH06239858A (ja) 1994-08-30
EP0636128A1 (en) 1995-02-01
PH30979A (en) 1997-12-23
WO1994019339A1 (en) 1994-09-01
AU666259B2 (en) 1996-02-01
TW259789B (2) 1995-10-11
CA2133207A1 (en) 1994-09-01
AU5978894A (en) 1994-09-14

Similar Documents

Publication Publication Date Title
CN1257891C (zh) 含氮五员环化合物
CN1029231C (zh) 三唑类抗霉菌剂的制备方法
CN1151136C (zh) 缩合哒嗪系化合物
CN1206228C (zh) 作为nos抑制剂的n-杂环衍生物
CN1104419C (zh) 苯并吖庚因衍生物
CN1906189A (zh) 用于治疗呼吸系统疾病的1-乙酸-吲哚、-吲唑和-苯并咪唑衍生物
CN1054124C (zh) 氨基喹啉衍生物及其盐的应用
CN1168720C (zh) 芳基链烷酰基哒嗪化合物
CN1684951A (zh) 新的嘧啶胺衍生物及其用途
CN1047290A (zh) 咪唑并哒嗪及其制备和反用
CN1798744A (zh) 作为nmda/nr2b拮抗剂的3-氟-哌啶化合物
CN1061350C (zh) 2,7-取代的八氢-吡咯并[1,2-a]吡嗪衍生物
CN1113240A (zh) 噁唑烷酮衍生物的制备方法
CN1505624A (zh) 哌嗪子基衍生物及其作为pde4抑制剂的用途
CN1131213C (zh) 喹诺酮衍生物抗血栓形成药
CN1184221C (zh) 有7-(7-氨甲基-5-氮杂螺[2,4]庚烷)取代基的新喹啉羧酸衍生物及其制备方法
CN1080920A (zh) 新喹啉衍生物及其制备方法
CN1856491A (zh) 作为可诱导的no合成酶抑制剂的咪唑并吡啶衍生物
CN1177353A (zh) 具有三环式稠合杂环的新颖的奎宁环衍生物
CN1349527A (zh) 取代的苯并内酰胺化合物
CN1045955C (zh) 喹啉衍生物及其制法和用途以及含该衍生物的药物组合物
CN1297558C (zh) 新的4-氧代-4,6,7,8-四氢-吡咯并[1,2-a]吡嗪-6-甲酰胺化合物,其制备方法和包含它们的药物组合物
CN1089341C (zh) 吡啶酮羧酸衍生物及其合成中间体和用途
CN101058573A (zh) 2-腙代三嗪类化合物,其制备方法和以该化合物为活性成分的药物组合物及其用途
HK1048472B (zh) 钠-氢交换剂1型抑制剂晶体

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned